Company CVAbout Decipher Labs Ltd 
Decipher Labs Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September, 1986 and was converted into a Public Limited Company in Jun.'92. The company was promoted by Suchit Mohan Lal and Ajay Karan.
Company Coordinates
Company Details
4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2 Hyderabad Telangana : 500034
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 10.10 Cr
Number of Shares
1.01 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
20-Dec-2019
1.01
10.10
2100000
10
Preferential basis
20-Dec-2019
1.01
10.10
2100000
10
Preferential basis
01-Oct-2011
8
8.00
7676860
10
Scheme of Arrangement
01-Oct-2011
8
8.00
7676860
10
Scheme of Arrangement
19-Sep-2011
32.31
0.32
0
1
Capital Reduction
19-Sep-2011
3.23
0.32
-2908260
10
Consolidation of Shares
19-Sep-2011
32.31
0.32
0
1
Capital Reduction
19-Sep-2011
3.23
0.32
-2908260
10
Consolidation of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Ajjarapu Janakiram (16.43%)
Highest Public shareholder
Seshu Srinivas Akula (3.8%)
Individual Investors Holdings
78.73%
Board of Directors
Management
Designation
Remuneration
Sushant Mohan Lal
Executive Director
3.0 lacs
G Venkateswara Rao
Independent Director
0
Megha Agarwal
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Material purchased
0.6725
0%
Material purchased
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharma Goods - Tablets, Liquids & Capsules
0.50
100.00%
Pharma Goods - Tablets, Liquids & Capsules
Stock DNARevenue and Profits:
Net Sales:
4 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
Pharmaceuticals & Biotechnology
INR 10 Cr (Micro Cap)
NA (Loss Making)
34
0.00%
-0.02
-42.37%
0.51
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
